Breast cancer micrometastases: Different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata

Clinical and Experimental Metastasis

Volumn 20, Issue 5, 2003, Pages 471-479

  Nicola, Maria Helena A ^a,b   Bizon, Rosana ^a   Machado, Janaina J S ^a   Sollero, Tereza ^a   Rodarte, Renato S ^a   Nobre, João S ^a   Magalhães, Maurício M ^a   Takiya, Christina M ^a   Borojevic, Radovan ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Ctro Fed de Educ Tecnologica   (Brazil)

^c Cidade Univ   (Brazil)

Author keywords

Autocrine loop; Bone marrow; Breast cancer; Hepatocyte growth factor; Micrometastases; Stroma

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; BONE MARROW; BONE MARROW METASTASIS; BREAST; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CARCINOMA CELL; CELL ADHESION; CELL INTERACTION; CIRCULATION; CONNECTIVE TISSUE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MESENCHYME; MICROENVIRONMENT; PRECANCER; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0042236567     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025462417256     Document Type: Article

References (34)

1. Greaves M. Cancer. The Evolutionary Legacy. Oxford: Oxford University Press 2000.
2. Ronnov-Jessen L, Petersen OW, Bissel MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stroma reaction. Physiol Rev 1996; 76: 69-125.
3. Wernert N. The multiple roles of tumour stroma. Virchows Arch 1997; 430: 433-43.
4. Dingemans KP, Zeeman-Boeschoten IM, Keep RF et al. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer 1993; 54: 1010-6.
5. Yoshinaga Y, Matsuno Y, Fujita S et al. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 1993; 84: 1150-8.
6. Singer C, Rasmussen A, Smith HS. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: Evidence for paracrine function. Cancer Res 1995; 55: 2448-54.
7. Foulds L. The experimental study of tumour progression. Cancer Res 1954; 14: 327-39.
8. Magennis DP. Angiogenesis: A new prognostic marker for breast cancer. Br J Biomed Sci 1998; 55: 214-20.
9. Abou-Ghalia A, Silva O, Vredenburgh JJ et al. Advances in the detection of marrow micrometastases in breast cancer. Cancer Ther Control 1994; 4: 43-7.
10. Mansi JL, Gogas H, Bliss JM et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 1999; 354: 197-202.
11. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999; 91: 1113-24.
12. Braun S, Kentenich C, Janni W et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumour cells in bone marrow of high-risk breast cancer patient. J Clin Oncol 2000; 18: 80-6.
13. Pantel K, Schlimok G, Braun S et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993; 85: 1419-23.
14. Braun S, Pantel K. Biological characteristics of micrometastatic cancer cells in bone marrow. Cancer Metast Rev 1999; 18: 75-90.
15. Lord B. Biology of the hematopoietic stem cell. In Potten CS (ed): Stem Cells. London: Academic Press 1997; 401-22.
16. Brooks B, Bundred NJ, Howell A et al. Investigation of mammary epithelial cell-bone marrow stroma interactions using primary human cell culture as a model. Int J Cancer 1997; 73: 690-6.
17. Hombauer H, Minguell JJ. Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 2000; 82: 1290-6.
18. Luppi M, Morselli M, Bandieri E et al. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 1996; 7: 619-24.
19. Zippelius A, Kufer P, Honold G et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997; 15: 2701-8.
20. Tuxhorn JA, Ayala GE, Smith MJ et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodelling. Clin Cancer Res 2002; 8: 2912-23.
21. Siler U, Seiffer M, Puch S et al. Characterization and functional analysis of laminin isoforms in human bone marrow. Blood 2000; 96: 4194-203.
22. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4.
23. Sappino AP, Schürch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63: 144-61.
24. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999; 181: 67-73.
25. Pelkey TJ, Frierson HF, Bruns DE. Molecular and immunological detection of circulating tumour cells and micrometastases from solid tumors. Clin Chem 1996; 42: 1369-81.
26. Price JE. Host-tumour interactions in the progression of breast cancer metastases. In Vivo 1994; 8: 145-54.
27. van Roozendaal CE, van Ooijen B, Klijn JG et al. Stromal influences on breast cancer cell growth. Br J Cancer 1992; 65: 77-81.
28. Shekhar MPV, Werdell J, Santner SJ et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: Implications for tumour development and progression. Cancer Res 2001; 61: 1320-6.
29. van Roozendaal CE, Gillis AJ, Klijn JG et al. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Lett 1998; 437: 107-11.
30. Brouty-Boye D, Magnien V. Myofibroblast and concurrent ED-B fibronectin phenotype in human stromal cells cultures from non-malignant and malignant breast tissue. Eur J Cancer 1994; 30A: 66-73.
31. Sesslar SP, Nakamura T, Byers S. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 1993; 53: 1233-8.
32. Bellusci S, Moens G, Gaudino G et al. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 1994; 9: 1091-9.
33. Jin L, Fuchs A, Achnitt SJ et al. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 1997; 79: 749-760.
34. Tokunou M, Niki T, Egychi K et al. c-MET expression in myofibroblasts - role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol 2001; 158: 1451-63.